Dr. Edward R. Broun, MD

Dr. Broun practices at The Jewish Hospital - Mercy Health in Cincinnati, Ohio, part of Bon Secours Mercy Health.

Dr. Broun's NPI, 1295728459, was assigned on August 23, 2005. Dr. Broun graduated from Saint Louis University School Of Medicine in 1982. Dr. Broun holds Ohio license 35070569.

Dr. Broun's primary practice is The Jewish Hospital - Mercy Health, at 4777 East Galbraith Road, Cincinnati, OH 45236 in Hamilton County. The practice phone is (513) 686-3000.

Dr. Broun's primary practice is The Jewish Hospital - Mercy Health in Cincinnati, Ohio, part of Bon Secours Mercy Health. The medical group on file is OHC - Oncology Hematology Care.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Broun practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Broun's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Broun is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Broun's licenses on file in 4 states: Ohio, Indiana, Kentucky and Missouri.

Dmand AI lists breast cancer, chronic leukemia, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Broun treats.

CMS data shows 260 Medicare services from Dr. Broun across 3 procedure codes in 2024, for 66 Medicare patients. Medicare paid $23,602 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 66 Medicare patients who saw Dr. Broun in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Broun's median patient age at 74, with 73% women.

In 2024, Dr. Broun wrote 148 Medicare Part D claims for 39 patients. 99% of them were for generic drugs. CMS names the drug for 44 of them, across 3 drugs with 11 or more claims each, at $591 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Dmand AI links 37 papers to Dr. Broun in 2018. 2018 was the busiest year, with 2. The most frequent topics are Bone Marrow Transplantation, Antineoplastic Combined Chemotherapy Protocols and Transplantation, Autologous. Dr. Broun has published most often in Bone Marrow Transplant. Dr. Broun's most frequent co-authors are Guido Tricot, MD, John F. Dipersio, MD and Robert Alan Hromas, MD.

Dmand AI links Dr. Broun to 11 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Leukemia, Megakaryoblastic, Acute, Leukemia, Erythroblastic, Acute and Anemia, Aplastic. Center for International Blood and Marrow Transplant Research sponsors the most, 2.

CMS Open Payments shows 37 general payments to Dr. Broun from 15 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 80% of the total. Bristol-Myers Squibb Company paid the most, $1,976. It also lists 3 research payments totaling $5,369 from 2023 to 2024.

Dmand AI lists 3 awards for Dr. Broun, most recently CMS Stage 1 2012 in 2012.

Dr. Broun graduated from Saint Louis University School Of Medicine in 1982. Dr. Broun is a member of ASCO and ASH.

Dr. Broun is in network with 19 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.